Search Results Search Sort by RelevanceMost Recent Policy Forum Aug 2019 Should a Law Governing the Pharmaceutical Market Be Ethically Examined Based on Its Intent or Its Practical Applications? Jordan M. Warchol, MD, MPH In 1984, Hatch-Waxman tried to balance drug innovation against availability; it was tested in the US Supreme Court in 2013. AMA J Ethics. 2019;21(8):E661-667. doi: 10.1001/amajethics.2019.661. Original Research Jan 2022 Using GIS to Analyze Inequality in Access to Dental Care in the District of Columbia Jennita Davis, Meirong Liu, PhD, Dennis Kao, PhD, Xinbin Gu, MD, PhD, and Gail Cherry-Peppers, DDS, MS High-resolution geographic information system tools map all general dentistry and periodontal practice locations as key sources of health inequity. AMA J Ethics. 2022;24(1):E41-47. doi: 10.1001/amajethics.2022.41 Case and Commentary Apr 2021 How Should Clinicians Execute Critical Force Interventions With Compassion, Not Just Harm Minimization, as a Clinical and Ethical Goal? Robert L. Trestman, PhD, MD and Kishore Nagaraja, MD Establishing criteria for compassion maximization would help us do better than harm minimization. AMA J Ethics. 2021;23(4):E292-297. doi: 10.1001/amajethics.2021.292. Case and Commentary Apr 2021 How Should Compassion Be Expressed as a Primary Clinical and Ethical Value in Anorexia Nervosa Intervention? Melissa Lavoie, MD and Angela S. Guarda, MD For an adolescent patient with extreme anorexia nervosa, steps for expressing compassion during a force intervention need to be clear. AMA J Ethics. 2021;23(4):E298-304. doi: 10.1001/amajethics.2021.298. Medicine and Society Jul 2021 How Pharmaceuticals Mask Health and Social Inequity Enrico G. Castillo, MD, MSHPM and Joel Tupper Braslow, MD, PhD Pharmaceuticals make symptoms and biological drug targets more visible but can render individual and community suffering less visible. AMA J Ethics. 2021;23(7):E542-549. doi: 10.1001/amajethics.2021.542.
Policy Forum Aug 2019 Should a Law Governing the Pharmaceutical Market Be Ethically Examined Based on Its Intent or Its Practical Applications? Jordan M. Warchol, MD, MPH In 1984, Hatch-Waxman tried to balance drug innovation against availability; it was tested in the US Supreme Court in 2013. AMA J Ethics. 2019;21(8):E661-667. doi: 10.1001/amajethics.2019.661.
Original Research Jan 2022 Using GIS to Analyze Inequality in Access to Dental Care in the District of Columbia Jennita Davis, Meirong Liu, PhD, Dennis Kao, PhD, Xinbin Gu, MD, PhD, and Gail Cherry-Peppers, DDS, MS High-resolution geographic information system tools map all general dentistry and periodontal practice locations as key sources of health inequity. AMA J Ethics. 2022;24(1):E41-47. doi: 10.1001/amajethics.2022.41
Case and Commentary Apr 2021 How Should Clinicians Execute Critical Force Interventions With Compassion, Not Just Harm Minimization, as a Clinical and Ethical Goal? Robert L. Trestman, PhD, MD and Kishore Nagaraja, MD Establishing criteria for compassion maximization would help us do better than harm minimization. AMA J Ethics. 2021;23(4):E292-297. doi: 10.1001/amajethics.2021.292.
Case and Commentary Apr 2021 How Should Compassion Be Expressed as a Primary Clinical and Ethical Value in Anorexia Nervosa Intervention? Melissa Lavoie, MD and Angela S. Guarda, MD For an adolescent patient with extreme anorexia nervosa, steps for expressing compassion during a force intervention need to be clear. AMA J Ethics. 2021;23(4):E298-304. doi: 10.1001/amajethics.2021.298.
Medicine and Society Jul 2021 How Pharmaceuticals Mask Health and Social Inequity Enrico G. Castillo, MD, MSHPM and Joel Tupper Braslow, MD, PhD Pharmaceuticals make symptoms and biological drug targets more visible but can render individual and community suffering less visible. AMA J Ethics. 2021;23(7):E542-549. doi: 10.1001/amajethics.2021.542.